A Better Way

Meet Darwin’s new Drug Review Tool

Meet Darwin’s new Drug Review Tool! With this solution, Abarca clients and Darwin™ users may access real-time information on drug maintenance and will have full visibility of ongoing medication changes to health plan formularies. What were the challenges users were...

2-25-2022

Abarca Health: Meet Darwin’s new Drug Review Tool

Beneficial impacts of SGLT-2 Inhibitors on Cardiovascular Disease

After several clinical trials associated with SGLT-2 inhibitors, this anti-diabetic drug class of medications is now linked to providing beneficial impacts on cardiovascular disease. Sodium-glucose cotransporter-2 inhibitors, also known as SGLT2 inhibitors, are antidiabetic drug classes that exert their function...

2-24-2022